(openPR) - Venture Capital Germany: in the period of 04th september – 17th september 2006 VC-facts, the analyst of venture capital and private equity, recorded 7 german venture capital-investments. The total amount was 30,4 mio. Euro. Investors were f.e. High-Tech Gründerfonds, Novartis Venture Fund, BioMedinvest, VI Partners, BayTech Venture Capital GmbH, ECOS Venture Capital Beteiligungs AG, Leonardo Venture GmbH & Co. KgaA.
Private Equity Germany: in the period of of 04th september – 17th september 2006 VC-facts recorded 16 private equity-transactions. Investors were f.e. Aurelius Investkapital AG, PPM Capital, Sigma Capital Management GmbH, Oaktree Capital Management, BayBG Bayerische Beteiligungsgesellschaft, S-Partner Kapital AG, ARQUES Industries AG.
Venture Capital Europe: out of germany VC-facts recorded in the period of of 04th september – 17th september 2006 24 venture capital-investments. The total amount was 148 mio. euro. Investors were f.e. BankInvest Bio Venture, Vækstfonden, CDC Entreprises Innovation, LD Pensions, AGF Private Equity, A/S Dansk Erhvervs-investering, Life Sciences Partners, Atlas Venture, Partech International, EuroUs Venture, Sofinnova Partners, Vertex Venture Capital, GIMV, Siparex Ventures, Techfund, Sophia Eurolab, Emertec Gestion, AXA Private Equity, Alven Capital.
About VC-facts:
Since 2002 VC-facts analyse the venture capital-scene in europe and the private equity-market in the german speaking area. The extensive VC-facts database contains all details of the transactions (investors, lawyers, advisors, contacts,..) and through our products and services we offer valuable insight into the trends in private equity and venture capital and its investment climate.
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Newsfeed
Store this image in big size
